CIK 0001681087 · Non-accelerated filer<br>Smaller reporting company
Tectonic Therapeutic, Inc.
Sign in to watch- Ticker
- TECX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- NY
- Entity type
- operating
- EIN
- 810710585
- Phone
- (339) 666-3320
- Business address
- 490 ARSENAL WAY, SUITE 200, WATERTOWN, MA
- Former names
- AvroBio, Inc., AVROBIO, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $13,920
- in 2 filings, $14K under 10b5-1 plans
Net −$13,920. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 86 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-06-30 | McNamara Peter Chief Scientific Officer | Sale 10b5-1 | −172 | $35.00 | $6K | 55,285 |
| 2026-06-30 | McNamara Peter Chief Scientific Officer | Option exercise · Employee Stock Option (Right to Buy) 10b5-1 | −172 | 7,873 | ||
| 2026-06-20 | REICIN ALISE Chief Executive Officer | Shares withheld for taxes | −924 | $30.34 | $28K | 310,623 |
| 2026-06-11 | Lochner Daniel Chief Financial Officer | Grant or award · Performance Stock Option (Right to Buy) | +7,500 | 7,500 | ||
| 2026-06-09 | Vitorovic Stefan Director | Grant or award · Stock Option (Right to Buy) | +10,200 | 10,200 | ||
| 2026-06-09 | Tipirneni Praveen P. Director | Grant or award · Stock Option (Right to Buy) | +10,200 | 10,200 | ||
| 2026-06-09 | Donenberg Phillip B. Director | Grant or award · Stock Option (Right to Buy) | +10,200 | 10,200 | ||
| 2026-06-09 | SPRINGER TIMOTHY A Director | Grant or award · Stock Option (Right to Buy) | +10,200 | 10,200 | ||
| 2026-06-08 | Chutter Jessica Caroline Director | Grant or award · Stock Option (Right to Buy) | +20,400 | 20,400 | ||
| 2026-05-04 | Ruddy Marcella K. Chief Medical Officer | Sale 10b5-1 | −1,065 | $30.00 | $32K | 67,682 |
| 2026-04-01 | Ruddy Marcella K. Chief Medical Officer | Sale 10b5-1 | −1,000 | $31.05 | $31K | 68,747 |
| 2026-04-01 | Nader Francois Director | Grant or award · Stock Option (Right to Buy) | +20,400 | 20,400 | ||
| 2026-03-06 | Ruddy Marcella K. Chief Medical Officer | Sale 10b5-1 | −10,000 | $30.00 | $300K | 69,747 |
| 2026-03-06 | McNamara Peter Chief Scientific Officer | Option exercise 10b5-1 | +2,500 | $2.38 | $6K | 61,332 |
| 2026-03-06 | McNamara Peter Chief Scientific Officer | Option exercise 10b5-1 | +215 | $14.71 | $3K | 61,547 |
| 2026-03-06 | McNamara Peter Chief Scientific Officer | Sale 10b5-1 | −6,047 | $30.00 | $181K | 55,500 |
| 2026-03-06 | McNamara Peter Chief Scientific Officer | Sale 10b5-1 | −215 | $35.00 | $8K | 55,285 |
| 2026-03-06 | McNamara Peter Chief Scientific Officer | Option exercise · Employee Stock Option (Right to Buy) 10b5-1 | −2,500 | 31,959 | ||
| 2026-03-06 | McNamara Peter Chief Scientific Officer | Option exercise · Employee Stock Option (Right to Buy) 10b5-1 | −215 | 8,045 | ||
| 2026-03-04 | Ruddy Marcella K. Chief Medical Officer | Grant or award | +26,500 | 79,747 |
Page 2 of 10 · 188 trades